The BioMedical Admissions Test (BMAT) was an aptitude test used as part of the admissions process for Medicine, Biomedical Sciences and Dentistry in some universities in the United Kingdom, Singapore, Spain, Malaysia, Thailand, Hungary, Croatia and the Netherlands.
In 2023, Cambridge Assessment announced that it would withdraw from the admissions test market and cease provision of the BMAT examination.
The vast majority of other universities at the time, especially in the United Kingdom, used an alternative admissions assessment - the UCAT.
This section tested the ability to apply scientific knowledge typically covered in school Science and Mathematics by the age of 16 (for example, GCSE in the UK and IGCSE internationally).
This section tested the ability to select, develop and organise ideas, and to communicate them in writing, concisely and effectively.
The scale was designed so that typical candidates who are invited for interview at the most highly competitive medical courses score around 5.0.
BMAT did not require a lot of extra study as it is designed to test skills and knowledge that candidates are expected to already have.
Practice materials, including the test specification, practice questions, past papers, and an Assumed Subject Knowledge guide for Section 2 are available to candidates for free from the Cambridge Assessment Admissions Testing website.
and that "Schools who wish to assess scientific knowledge independently of A-levels may find BMAT Section 2 useful.